Stelvio Therapeutics Company
Stelvio Oncology is focused on delivering precision medicine diagnostics and novel therapeutics for glioblastoma.
Technology:
Personalised Medicine
Industry:
Early Drug Development
Headquarters:
San Diego, California, United States
Founded Date:
2017-03-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
2
Estimated Revenue:
Less than $1M
Last Funding Date:
2017-05-05
Last Funding Type:
Seed
Register and Claim Ownership